When You Can't Get Brilinta, What Are Your Options?

If you've been prescribed Brilinta (Ticagrelor) but can't fill your prescription — whether due to cost, availability, or insurance restrictions — you're probably wondering what alternatives exist. The good news is that there are other medications in the same class that may work for your condition.

But here's the important part: never switch from Brilinta to another medication on your own. Antiplatelet drugs have different properties, and what works for one patient may not be safe for another. Always talk to your cardiologist or prescribing doctor before making any changes.

This guide will walk you through what Brilinta does, how it works, and the most common alternatives your doctor may consider.

What Is Brilinta and What Does It Treat?

Brilinta is the brand name for Ticagrelor, a prescription antiplatelet medication manufactured by AstraZeneca. It's classified as a P2Y12 platelet inhibitor — one of the most important classes of drugs used to prevent dangerous blood clots in people with heart disease.

The FDA has approved Brilinta for three main uses:

• Acute coronary syndrome (ACS): Reducing the risk of cardiovascular death, heart attack, and stroke after a heart event
• Coronary artery disease (CAD): Preventing heart attacks and strokes in patients with a history of heart attack
• Acute ischemic stroke: Reducing the risk of recurrent stroke within the first 30 days

Brilinta is taken twice daily — either as a 90 mg tablet (for ACS and stroke) or a 60 mg tablet (for long-term CAD prevention) — alongside low-dose aspirin (75–100 mg per day). For a deeper dive, read our guide: What Is Brilinta? Uses, Dosage, and What You Need to Know.

How Does Brilinta Work?

Brilinta works by reversibly blocking the P2Y12 receptor on blood platelets. This receptor normally responds to a chemical signal called ADP (adenosine diphosphate) that tells platelets to clump together. By blocking this signal, Brilinta prevents platelets from aggregating into dangerous clots.

What makes Brilinta unique among P2Y12 inhibitors:

• Not a prodrug: Unlike Clopidogrel and Prasugrel, Brilinta doesn't need to be converted by your liver to become active. It works directly.
• Reversible binding: Brilinta's effect wears off faster than Clopidogrel or Prasugrel, which bind permanently to platelets. This means platelet function recovers within about 3–5 days of stopping Brilinta.
• No genetic variability: Some patients are "poor metabolizers" of Clopidogrel (due to CYP2C19 gene variants), meaning Clopidogrel doesn't work well for them. Brilinta doesn't have this problem.

For a more detailed explanation, see our post on how Brilinta works.

Alternatives to Brilinta

If you can't get Brilinta, your doctor may consider one of the following alternatives. Each has its own strengths, weaknesses, and suitability depending on your medical history.

1. Clopidogrel (Plavix)

Clopidogrel is the most widely used P2Y12 inhibitor in the world and the most common alternative to Brilinta. It has been available as an affordable generic for over a decade.

How it compares to Brilinta:

• Mechanism: Like Brilinta, Clopidogrel blocks the P2Y12 receptor — but it does so irreversibly and is a prodrug that must be activated by liver enzymes (CYP2C19).
• Effectiveness: In the landmark PLATO trial, Brilinta was shown to be more effective than Clopidogrel at reducing cardiovascular death, heart attacks, and strokes in ACS patients.
• Genetic variability: About 2–14% of people (depending on ethnicity) are poor CYP2C19 metabolizers, meaning Clopidogrel may not work effectively for them.
• Cost: Generic Clopidogrel is very affordable — often $4 to $15 per month.
• Dosing: 75 mg once daily (after a 300–600 mg loading dose), compared to Brilinta's twice-daily dosing.

Clopidogrel may be appropriate if cost is a major barrier, if you have a low bleeding risk, or if genetic testing confirms you're a normal metabolizer.

2. Prasugrel (Effient)

Prasugrel is another P2Y12 inhibitor, considered more potent than Clopidogrel but with a higher bleeding risk.

How it compares to Brilinta:

• Mechanism: Like Clopidogrel, Prasugrel is an irreversible prodrug — but it's more reliably activated and isn't affected by CYP2C19 genetic variants.
• Effectiveness: Very effective at preventing stent thrombosis and recurrent events after PCI.
• Bleeding risk: Higher risk of major bleeding compared to both Clopidogrel and Brilinta. Not recommended for patients over 75, patients weighing under 60 kg, or those with a history of stroke or TIA.
• Cost: Generic Prasugrel is available and typically costs $15 to $50 per month.
• Dosing: 10 mg once daily (after a 60 mg loading dose).

Prasugrel may be a good option for younger patients undergoing PCI who need strong platelet inhibition and don't have contraindications.

3. Cangrelor (Kengreal)

Cangrelor is an intravenous P2Y12 inhibitor used in the hospital during PCI procedures. It's not a daily oral medication, so it's not a direct replacement for Brilinta in everyday life. However, it can be useful in acute settings when a patient can't take oral medications.

Key features:

• Rapid onset (within 2 minutes) and rapid offset (within 60 minutes)
• IV administration only — hospital use
• Bridges patients to oral P2Y12 therapy after a procedure

4. Generic Ticagrelor

This isn't technically an "alternative" — it's the same drug. But if you can't find or afford brand-name Brilinta, generic Ticagrelor is now widely available from multiple manufacturers. It's FDA-approved, therapeutically equivalent, and can cost as little as $30 per month with a discount card. Ask your pharmacist about switching.

For help locating it, use Medfinder to find pharmacies near you that have it in stock.

How to Talk to Your Doctor About Switching

If you're considering an alternative to Brilinta, prepare for the conversation with your doctor:

• Explain the barrier: Is it cost, availability, side effects, or insurance denial? Your doctor needs to know the reason to recommend the best alternative.
• Ask about genetic testing: If Clopidogrel is being considered, ask whether CYP2C19 testing is appropriate to ensure it will work for you.
• Discuss your bleeding risk: Some alternatives carry higher or lower bleeding risks, which matters for your specific situation.
• Don't stop first: Continue taking Brilinta until your doctor has prescribed and you've filled the replacement. Stopping antiplatelet therapy abruptly is dangerous.

For more about finding a prescriber who can help, see our guide: How to Find a Doctor Who Can Prescribe Brilinta Near You.

Final Thoughts

Brilinta is a highly effective antiplatelet medication, but it's not the only option. If you can't fill your prescription due to cost, availability, or insurance issues, there are real alternatives — from affordable generic Clopidogrel to same-drug generic Ticagrelor.

The key is to work with your doctor to find the option that's safest and most effective for your specific heart condition. Don't let a pharmacy problem turn into a health emergency.

Need help finding Brilinta or Ticagrelor in stock? Search on Medfinder to check real-time pharmacy availability near you.